PLUS1
2.56
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.09 | 3.64% | 2.56 | 2.48 | 2.6799 | 2.48 | 2.47 | 00:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.50 | 2.57 | 0.07 | 2.72% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,158 | 454,204 | $ 2.57 | $ 1,166,119 | 2,526,546 | 0.097 - 10.85 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:47:36 | 10 | $ 2.56 | USD |
Phio Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 11.73M | 4.58M | 1.86M | $ 21.00k | $ - | -19.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Phio Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/02/2020 | 17:01 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) |
| 6/02/2020 | 06:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 5/28/2020 | 17:17 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) |
| 5/12/2020 | 17:11 | Edgar (US Regulatory) | Securities Registration Statement (s-1) |
| 5/12/2020 | 16:37 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 5/12/2020 | 16:36 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 4/14/2020 | 17:17 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.27 | 6.48 | 2.28 | 2.97 | 12,683,280 | -2.71 | -51.42% |
| 1 Month | 2.42 | 6.48 | 2.08 | 2.94 | 3,531,845 | 0.14 | 5.79% |
| 3 Months | 2.21 | 6.48 | 1.50 | 2.76 | 1,344,506 | 0.35 | 15.84% |
| 6 Months | 0.1505 | 10.85 | 0.13 | 1.76 | 1,238,208 | 2.41 | 1,601.0% |
| 1 Year | 0.44 | 10.85 | 0.097 | 1.36 | 834,992 | 2.12 | 481.82% |
| 3 Years | 0.39 | 10.85 | 0.097 | 1.12 | 738,910 | 2.17 | 556.41% |
| 5 Years | 0.39 | 10.85 | 0.097 | 1.12 | 738,910 | 2.17 | 556.41% |
Phio Pharmaceuticals Description
| Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. |
